{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:18:13Z","timestamp":1793787493408,"version":"4.6.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.eclinm.2024.102727","type":"journal-article","created":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T03:27:54Z","timestamp":1720841274000},"page":"102727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Global epidemiology, natural history, maternal-to-child transmission, and treatment with DAA of pregnant women with HCV: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2417-7045","authenticated-orcid":false,"given":"Joo Wei Ethan","family":"Quek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing Hong","family":"Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"En Qi","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7487-714X","authenticated-orcid":false,"given":"Ambrose Hon-Lam","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu Bakar Bin","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4532-4347","authenticated-orcid":false,"given":"Jarell Jie-Rae","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindie H.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0727-1183","authenticated-orcid":false,"given":"Yu Jun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2024.102727_bib3","doi-asserted-by":"crossref","DOI":"10.1007\/s12072-023-10547-4","article-title":"Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study","author":"Wong","year":"2023","journal-title":"Hepatol Int"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102727_bib4","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3390\/v15071489","article-title":"Treatment outcomes of sofosbuvir\/velpatasvir\/Voxilaprevir in direct-acting antiviral-Experienced hepatitis C virus patients: a systematic review and meta-analysis","volume":"15","author":"Devan","year":"2023","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102727_bib5","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.4254\/wjh.v14.i6.1248","article-title":"Efficacy and safety of sofosbuvir\/velpatasvir with or without ribavirin in hepatitis C genotype 3 compensated cirrhosis: a meta-analysis","volume":"14","author":"Loo","year":"2022","journal-title":"World J Hepatol"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102727_bib6","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/jgh.15324","article-title":"Efficacy and safety of sofosbuvir\/velpatasvir in a real-world chronic hepatitis C genotype 3 cohort","volume":"36","author":"Wong","year":"2021","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.eclinm.2024.102727_bib7","series-title":"Hepatitis C surveillance in the United States, 2018","year":"2020"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102727_bib8","first-page":"21","article-title":"Prenatal nicotine or cannabis exposure and offspring neurobehavioral outcomes","volume":"139","author":"Smid","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102727_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/jvh.12628","article-title":"Higher incidence of HCV in females compared to males who inject drugs: a systematic review and meta-analysis","volume":"24","author":"Esmaeili","year":"2017","journal-title":"J\u00a0Viral Hepat"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102727_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217811","article-title":"Injecting-related trust, cooperation, intimacy, and power as key factors influencing risk perception among drug injecting partnerships. Nikolopoulos G\u039a","volume":"14","author":"Morris","year":"2019","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.eclinm.2024.102727_bib11","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/cid\/ciy585","article-title":"Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection","volume":"67","author":"AASLD-IDSA HCV Guidance Panel","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102727_bib12","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.5114\/aoms.2019.83644","article-title":"Perinatal transmission of hepatitis C virus: an update","volume":"16","author":"El-Shabrawi","year":"2020","journal-title":"Arch Med Sci"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102727_bib13","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1055\/s-0040-1709185","article-title":"Hepatitis C virus infection in children and pregnant women: an updated review of the literature on screening and treatments","volume":"10","author":"Ragusa","year":"2020","journal-title":"Am J Perinatol Rep"},{"key":"10.1016\/j.eclinm.2024.102727_bib14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jpeds.2018.07.006","article-title":"Perinatal transmission of hepatitis C virus: defining the cascade of care","volume":"203","author":"Epstein","year":"2018","journal-title":"J\u00a0Pediatr"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102727_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.24770","article-title":"Trends in the prevalence of hepatitis C infection during pregnancy and maternal-infant outcomes in the US, 1998 to 2018","volume":"6","author":"Chen","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eclinm.2024.102727_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jclinepi.2021.02.003","article-title":"Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement","volume":"134","author":"Page","year":"2021","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.eclinm.2024.102727_bib17","series-title":"Cochrane Handbook for systematic reviews of Interventions","article-title":"Chapter 10: analysing data and undertaking meta-analyses","year":"2023"},{"key":"10.1016\/j.eclinm.2024.102727_bib18","author":"Wells"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102727_bib19","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.aohep.2020.08.064","article-title":"A\u00a0systematic review and meta-analysis of the COVID-19 associated liver injury","volume":"19","author":"Wong","year":"2020","journal-title":"Ann Hepatol"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102727_bib20","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3350\/cmh.2023.0004","article-title":"Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis","volume":"29","author":"Wong","year":"2023","journal-title":"Clin Mol Hepatol"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102727_bib21","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/MCG.0000000000001478","article-title":"Efficacy and safety of statin for hepatocellular carcinoma prevention among chronic liver disease patients: a systematic review and meta-analysis","volume":"55","author":"Wong","year":"2021","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.eclinm.2024.102727_bib22","series-title":"Cochrane handbook for systematic reviews of interventions","article-title":"Chapter 25: assessing risk of bias in a non-randomized study","author":"Sterne","year":"2023"},{"key":"10.1016\/j.eclinm.2024.102727_bib24","series-title":"Cochrane Handbook for systematic reviews of interventions version 6.4","article-title":"Chapter 9: summarizing study characteristics and preparing for synthesis","author":"McKenzie","year":"2023"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102727_bib25","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/jech-2013-203104","article-title":"Meta-analysis of prevalence","volume":"67","author":"Barendregt","year":"2013","journal-title":"J\u00a0Epidemiol Community Health"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102727_bib26","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"7109","key":"10.1016\/j.eclinm.2024.102727_bib27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"20","key":"10.1016\/j.eclinm.2024.102727_bib28","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A\u00a0modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102727_bib29","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3350\/cmh.2021.0015","article-title":"The impact of unrestricted access to direct-acting antiviral among incarcerated hepatitis C virus-infected patients","volume":"27","author":"Wong","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.eclinm.2024.102727_bib30","author":"Schwarzer"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102727_bib31","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.45424","article-title":"Characteristics and treatment rate of patients with hepatitis C virus infection in the direct-acting antiviral era and during the COVID-19 pandemic in the United States","volume":"5","author":"Nguyen","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102727_bib32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.47102\/annals-acadmedsg.202347","article-title":"Minimal monitoring is a safe but underutilised strategy for hepatitis C virus treatment in Singapore","volume":"52","author":"Tay","year":"2023","journal-title":"Ann Acad Med Singap"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102727_bib33","first-page":"99","article-title":"Hepatitis C virus testing during pregnancy after universal screening recommendations","volume":"140","author":"Kaufman","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102727_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy043","article-title":"Risk-based hepatitis C screening in pregnancy is less reliable than universal screening: a retrospective chart review","volume":"5","author":"Boudova","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102727_bib35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2478\/jtim-2020-0039","article-title":"Delays and gaps in progressing through the hepatitis C virus cascade of care: an underserved safety-net hospital experience","volume":"8","author":"Gomes","year":"2020","journal-title":"J\u00a0Transl Intern Med"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102727_bib36","doi-asserted-by":"crossref","first-page":"e3355","DOI":"10.1093\/cid\/ciaa362","article-title":"Cost-effectiveness of antenatal rescreening among pregnant women for hepatitis C in the United States","volume":"73","author":"Chaillon","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102727_bib37","doi-asserted-by":"crossref","DOI":"10.1097\/CLD.0000000000000140","article-title":"Acceptability of hepatitis C screening and treatment during pregnancy in pregnant women in Egypt, Pakistan, and Ukraine: a cross-sectional survey","volume":"23","author":"Scott","year":"2024","journal-title":"Clin Liver Dis"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102727_bib38","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/hep4.1264","article-title":"Evaluating women's preferences for hepatitis C treatment during pregnancy","volume":"2","author":"Kushner","year":"2018","journal-title":"Hepatol Commun"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102727_bib39","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jhep.2020.11.027","article-title":"Changing epidemiology, implications, and recommendations for hepatitis C in women of childbearing age and during pregnancy","volume":"74","author":"Kushner","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102727_bib40","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2018.11.013","article-title":"Epidemiology and natural history of hepatitis C virus infection among children and young people","volume":"70","author":"Modin","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102727_bib41","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/AOG.0000000000005300","article-title":"Viral hepatitis in pregnancy: ACOG clinical practice guideline No. 6","volume":"142","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102727_bib42","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/jvh.13377","article-title":"Estimating paediatric hepatitis C prevalence in the United States","volume":"27","author":"Rahal","year":"2020","journal-title":"J\u00a0Viral Hepat"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102727_bib43","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1053\/j.gastro.2008.02.082","article-title":"Long-Term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease","volume":"134","author":"Bortolotti","year":"2008","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102727_bib44","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-3273","article-title":"Hepatitis C virus screening among children exposed during pregnancy","volume":"141","author":"Chappell","year":"2018","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102727_bib45","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.amepre.2018.05.029","article-title":"Hepatitis C virus in women of childbearing age, pregnant women, and children","volume":"55","author":"Schillie","year":"2018","journal-title":"Am J Prev Med"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024003067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024003067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T16:10:21Z","timestamp":1728403821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537024003067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":42,"alternative-id":["S2589537024003067"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102727","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global epidemiology, natural history, maternal-to-child transmission, and treatment with DAA of pregnant women with HCV: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102727","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102727"}}